Radiomics and AI-Based Prediction of MGMT Methylation Status in Glioblastoma Using Multiparametric MRI: A Hybrid Feature Weighting Approach
<b>Background/Objectives</b>: Glioblastoma (GBM) is a highly aggressive primary central nervous system tumor with a median survival of 14 months. MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation status is a key biomarker as a prognostic indicator and a predictor of chem...
Saved in:
| Main Authors: | Erdal Tasci, Ying Zhuge, Longze Zhang, Holly Ning, Jason Y. Cheng, Robert W. Miller, Kevin Camphausen, Andra V. Krauze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/10/1292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of MGMT methylation status in glioblastoma patients based on radiomics feature extracted from intratumoral and peritumoral MRI imaging
by: Wang-Sheng Chen, et al.
Published: (2025-07-01) -
Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patients
by: Yeong Chul Yun, et al.
Published: (2025-08-01) -
Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway
by: Xiaohang Cui, et al.
Published: (2025-07-01) -
Application of Radiomics in Predicting the Prognosis of Medulloblastoma in Children
by: Jiashu Chen, et al.
Published: (2025-03-01) -
Towards Precision Medicine in Sinonasal Tumors: Low-Dimensional Radiomic Signature Extraction from MRI
by: Riccardo Biondi, et al.
Published: (2025-06-01)